Search
Meeting Overview:
Clinical trials are vital to progress in oncology, offering the most promising potential therapies and, often, serving as the treatment of choice for cancer patients. However, navigating the landscape of trial enrollment—especially for genitourinary malignancies—requires a specialized, collaborative, and patient-centered approach that is rarely incorporated in standard continuing medical education.
We invite you to join us for an innovative one-day multi-disciplinary educational meeting to bridge this critical gap. This forum convenes leading academic and community clinicians and researchers to enhance collaboration, share cutting-edge science, and strategize on best practices for clinical trial participation in kidney, bladder, and prostate cancer. Learning Objectives:
ANCO is putting a new spin on networking! Join us at SPIN SF in SoMa on Thursday, November 6th (the night before the Precision Oncology) for an evening of ping-pong, camaraderie, and connection. This event is curated specifically for our practitioner community to relax and connect before the symposium begins—and families and kids are welcome to join the fun!
When: Thursday, November 6th at 6:00 PM
Where: SPIN SF (SoMa)
What to Expect: Show up ready to rally! Enjoy open ping-pong tables, hosted food, and drinks while catching up with colleagues in a fun, relaxed environment.
Registration
ANCO Members: $30
Guests: Adults guests are $60 each and Children are $30
Families & Children: Welcome!
Eligibility Note: Reserved for practitioner members not affiliated with industry.
Transforming Tumor Profiling into Targeted Patient Care.
Precision oncology is rapidly changing the landscape of cancer care. With FDA approvals shifting toward molecular features rather than disease location, personalized treatment is no longer just a goal—it’s the standard.
However, with diagnostic technologies and targeted therapies evolving at a breathtaking pace, keeping up with clinical applications remains a challenge. Join ANCO & MOASC for an immersive symposium designed to help practicing oncologists and clinical care teams bridge the gap between cutting-edge diagnostics and patient outcomes.
Learning Objectives:
By participating this meeting, attendees will learn to:
Translate complex molecular tumor profiles and tumor-agnostic FDA approvals into personalized patient treatment plans.
Navigate current challenges and adopt new therapeutic opportunities in Gastrointestinal, Genitourinary, Lung, and Breast/Gynecologic cancers.
Utilize germline data alongside somatic diagnostic findings to guide comprehensive clinical decision-making.
Identify cross-tumor challenges in precision testing and apply best practices to overcome diagnostic barriers.
Partner with patient advocates to ensure biomarker-driven care plans remain patient-centered and accessible.
Join us at the 27th Multidisciplinary Management of Cancers: A Case-Based Approach!
The 27th Multidisciplinary Management of Cancers: A Case-Based Approach meeting will present the most current information on multidisciplinary approaches in clinical oncology. It will consist of tumor board cases covering breast, central nervous system, head and neck, hematologic malignancies, gastrointestinal, genitourinary, lymphoma, melanoma, supportive oncology and survivorship, and thoracic cancers.
Faculty will present the tumor board cases, followed by a discussion with a panel of surgical, radiation, and medical oncologists from Stanford, UC Davis, UC San Francisco, The Permanente Medical Group, and the practice community.
Apply to Become a Member
4225 Solano Ave, #764 Napa, CA 94558 Phone (415) 472-3960
Association of Northern California Oncologists © 2025 | Privacy Policy | Disclaimer